Elekta to launch MRI-LINAC equipments in Telangana
Elekta, a radiation therapy equipment manufacturer, has announced plans to launch Magnetic Resonance Imaging Guided Linear Accelerator (MRI-LINAC) equipments with the name ‘Elekta Unity’ in Telangana. This development aims to enhance cancer care capabilities and improve treatment outcomes for patients in the region.
image for illustrative purpose
Hyderabad: Elekta, a radiation therapy equipment manufacturer, has announced plans to launch Magnetic Resonance Imaging Guided Linear Accelerator (MRI-LINAC) equipments with the name ‘Elekta Unity’ in Telangana. This development aims to enhance cancer care capabilities and improve treatment outcomes for patients in the region.
The company has installed over 300 Linear Accelerator equipments out of its 500-above radiotherapy equipments in cancer care facilities in India. The company has ACCESS 2025 strategy to improve treatment availability, enhance awareness and education, and strengthen partnerships with healthcare providers and organisations.
With 22 lakh cancer cases registering in India, there is a need for a large number of equipment to treat the diseases and half of them to undergo radiation therapy. India has 0.4 LINACs available per ten lakh population, where this number should be 1 LINAC per 10 lakh population.
Elekta focuses on designs and customization of the low-cost radiation therapy equipment for India especially according to the needs of Tier-2, Tier-3 cities as there are more cancer cases registering.
Manikandan Bala, Managing Director, India, and Senior Vice President, Intercontinental, Elekta, said “We acknowledge the prominent concerns surrounding India’s cancer care scenario, including equitable access to care, affordability, the migration of patients to urban cities for treatment, and the shortage of skilled manpower. We are also committed to addressing these challenges by focusing on key areas such as improving awareness, affordability, and accessibility in cancer care.”
By working closely with stakeholders and implementing innovative solutions, we aim to make high-quality cancer treatment accessible to all individuals in need, Bala added.